METHOTREXATE , MYCOPHENOLIC ACID , AZATHIOPRINE , Tavneos 10 mg hard capsules, CYCLOPHOSPHAMIDE , -, RITUXIMAB, Placebo for AMG 569
20220159
Approved small_molecule active
Quick answer
METHOTREXATE , MYCOPHENOLIC ACID , AZATHIOPRINE , Tavneos 10 mg hard capsules, CYCLOPHOSPHAMIDE , -, RITUXIMAB, Placebo for AMG 569 for Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) is a Approved program (small_molecule) at Amgen Technology (Ireland) UC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amgen Technology (Ireland) UC
- Indication
- Antineutrophil cytoplasmic antibody-associated vasculitis (AAV)
- Phase
- Approved
- Modality
- small_molecule
- Status
- active